The World Bank Working for a World Free of Poverty Microdata Library
  • Data Catalog
  • About
  • Collections
  • Citations
  • Terms of use
  • Login
    Login
    Home / Central Data Catalog / IMPACT_EVALUATION / HTI_2015_HRBFIE-FBL_V01_M / variable [F8]
impact_evaluation

Etude d'Impact Du Financement Basé sur Les Résultats 2016, Enquête des Institutions de Santé (IS) - Etude de Base

Haiti, 2015 - 2016
Get Microdata
Reference ID
HTI_2015_HRBFIE-FBL_v01_M
DOI
https://doi.org/10.48529/e8hy-yz10
Producer(s)
Damien de Walque, Marion Cros (Consultante), Dr. Johnny Calonge, Dr. Samuel Raymond
Collection(s)
Impact Evaluation Surveys Fragility, Conflict and Violence
Metadata
Documentation in PDF DDI/XML JSON
Created on
May 24, 2017
Last modified
May 24, 2017
Page views
182386
Downloads
11396
  • Study Description
  • Data Description
  • Documentation
  • Get Microdata
  • Data files
  • F1_Personnel
  • F1_Principal
  • F1_Zones
    couvertes
  • F2_agents sante
  • F3_OD_CPN
  • F4_OD_Enfts
  • F5_Sortie_CPN
  • F6_Sortie_Enfts
  • F7_ASC

Médicaments administrés: (F6_0219iv)

Data file: F6_Sortie_Enfts

Overview

Valid: 545
Invalid: 0
Type: Discrete
Start: 530
End: 564
Width: 35
Range: -
Format: character

Questions and instructions

Categories
Value Category Cases
-1 170
31.2%
0 244
44.8%
00 1
0.2%
Acido fólico 5 mg 1
0.2%
Amox 2
0.4%
Antitussif 1
0.2%
Anttitussif 1
0.2%
Bacitracine hongueux 1
0.2%
Bactrim 240mg 1
0.2%
Bella-phen sp. 1
0.2%
Bromecine à défaut sirop 1cu 3f/j 1
0.2%
Co-trimoxazole 1
0.2%
Cotrim 100 ml 2f/J 1
0.2%
Cotrinoxazol 1
0.2%
Diphenydramine 1
0.2%
Dypirone 0,5cc 1
0.2%
Erytmomicine 1
0.2%
Hydrotherapie 1
0.2%
Ibuprofen 1
0.2%
Ibuprofène 1
0.2%
Loratadine 1
0.2%
Mucopax 120ml 1
0.2%
Multiples vitamine 2
0.4%
Multivitamine 2
0.4%
N.S goutte 1
0.2%
Neomicil 1
0.2%
Paracetamol 1
0.2%
Pediafen Goutte 1
0.2%
Pediaphène 1
0.2%
Piperacin 1
0.2%
Pipérazine susp 1
0.2%
Rapidal plus sp TID 1
0.2%
SRO 5
0.9%
Savon 1
0.2%
TMS sp 1 cu bid 1
0.2%
Tétracycline 1
0.2%
Vitamine c 2
0.4%
abendazol 2
0.4%
albendasol 1
0.2%
aminovit 2
0.4%
amox 3
0.6%
amox 250 mg 1
0.2%
amoxiciline 1
0.2%
amoxiciline susp 1
0.2%
amoxicilline 1
0.2%
antitussif 2
0.4%
anttitussif 1
0.2%
bebito savon. 1
0.2%
bioplex susp 1
0.2%
bébé sirop 1
0.2%
coscopin 1
0.2%
cotrim 4
0.7%
cotrimazole 1
0.2%
curof 1
0.2%
desirel 1
0.2%
desyvee 1
0.2%
digas 1
0.2%
erythrocyne 2
0.4%
fer 2
0.4%
fer up 100mg 1
0.2%
galocia 1
0.2%
hermovit 1
0.2%
illisible 3
0.6%
javon de castilla 1
0.2%
k-mox 1
0.2%
kamox 1
0.2%
kamox sp 1
0.2%
metronidazol 5
0.9%
metronidazol susp 1
0.2%
miconazol 1
0.2%
mucopax 1
0.2%
multivitamine 2
0.4%
métro 1
0.2%
p 2
0.4%
paracetamol 4
0.7%
paracetamol sirop 1
0.2%
pedialite 1
0.2%
rapidal 1
0.2%
rapidal plus 1
0.2%
solution de zinc 1
0.2%
sulfate de zinc 1
0.2%
tilvit 1
0.2%
tinvit sp 2
0.4%
tribomol 1
0.2%
tylenol 2
0.4%
tylvite 1
0.2%
tétracycline 1
0.2%
vita c. 1
0.2%
vitamine c 10
1.8%
vitamine c 5cc q am 1
0.2%
Ça folâtre sirop 1
0.2%
Écriture illisible 2
0.4%
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Back to Catalog
The World Bank Working for a World Free of Poverty
  • IBRD IDA IFC MIGA ICSID

© The World Bank Group, All Rights Reserved.

This site uses cookies to optimize functionality and give you the best possible experience. If you continue to navigate this website beyond this page, cookies will be placed on your browser. To learn more about cookies, click here.